Company / Book Value per Share
GeneDx Holdings Corp. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$11
FY2025
5-year range
$9.44 / $3.1M
FY2021-FY2025
Trend
+16.5%
vs FY2024
Sector context
#96 of 163
Health Care
What the data says
At $11, GeneDx Holdings Corp.'s book value per share ranks #96 of 163 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $11.
Based on SEC 10-K filings.
$11 in FY2025 with a 3-year CAGR of -93.9%.
Declined from $19.368 to $11 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -93.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 163 in Health CareTop 59% of 163This company $11 Sector average $47.415
▼
-76.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -93.9%, indicating a declining trend.
- In FY2025, book value per share increased 16.5% year-over-year.
- Ranks #96 out of 163 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11 | +16.5% |
| FY2024 | $9.44 | -51.3% |
| FY2023 | $19.368 | -100.0% |
| FY2022 | $49.4K | -98.4% |
| FY2021 | $3.1M | +4965.7% |
| FY2020 | -$64.3K | +91.0% |
| FY2019 | -$715.4K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026